Tag: PHOCUS trial

Phase 3 trial of Pexa-Vec for advanced liver cancer initiated in China

pharmanewsdaily- September 5, 2018

South Korean biotech company SillaJen and Hong Kong-based Lee's Pharmaceutical have enrolled the first patient in China for a phase 3 trial called PHOCUS which ... Read More